Search research articles
Contact Us
Filters
Showing results (1-10 of 14) with videos related to
Page
of 2
Sort By:
Methods in Cell Biology
|
January 1, 1976
Long-term preservation of the Ehrlich ascites tumor
W A Cassel
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)
|
December 1, 1970
An hypothesis for the mechanism by which an hemagglutinin inhibitor affects vaccinia virus
E Wible, W A Cassel
Medical Oncology and Tumor Pharmacotherapy
|
January 1, 1992
A ten-year follow-up on stage II malignant melanoma patients treated postsurgically with Newcastle disease virus oncolysate
W A Cassel, D R Murray
Natural Immunity and Cell Growth Regulation
|
January 1, 1988
Treatment of stage II malignant melanoma patients with a Newcastle disease virus oncolysate
W A Cassel, D R Murray
Infection and Immunity
|
March 1, 1972
Biological activity of a partially purified inhibitor of vaccinia virus hemagglutinin
S C Lau, W A Cassel
Applied Microbiology
|
October 1, 1974
Ehrlich ascites tumor preservation for fifteen years--a simple method
W A Cassel, K M McCaskill
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)
|
October 1, 1982
Light and electron microscopic studies of the pathogenesis of vaccinia virus infection in mouse brain
D C Bosse, W G Campbell, W A Cassel
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 24, 1999
Immunotherapy in malignant melanoma
W A Cassel, Z L Olkowski, D R Murray
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
November 11, 1975
The pathogenesis of Vaccinia virus toxicity. II. An electron microscopic study
H M Sottnek, W G Campbell, W A Cassel
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
November 11, 1975
The pathogenesis of Vaccinia virus toxicity. I. The role of virus-platelet interaction
H M Sottnek, W A Cassel, W G Campbell
Page
of 2
Search research articles
Search
Showing results (1-10 of 14) with videos related to
Sort By:
Page
of 2
Methods in Cell Biology
|
January 1, 1976
Long-term preservation of the Ehrlich ascites tumor
W A Cassel
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)
|
December 1, 1970
An hypothesis for the mechanism by which an hemagglutinin inhibitor affects vaccinia virus
E Wible, W A Cassel
Medical Oncology and Tumor Pharmacotherapy
|
January 1, 1992
A ten-year follow-up on stage II malignant melanoma patients treated postsurgically with Newcastle disease virus oncolysate
W A Cassel, D R Murray
Natural Immunity and Cell Growth Regulation
|
January 1, 1988
Treatment of stage II malignant melanoma patients with a Newcastle disease virus oncolysate
W A Cassel, D R Murray
Infection and Immunity
|
March 1, 1972
Biological activity of a partially purified inhibitor of vaccinia virus hemagglutinin
S C Lau, W A Cassel
Applied Microbiology
|
October 1, 1974
Ehrlich ascites tumor preservation for fifteen years--a simple method
W A Cassel, K M McCaskill
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)
|
October 1, 1982
Light and electron microscopic studies of the pathogenesis of vaccinia virus infection in mouse brain
D C Bosse, W G Campbell, W A Cassel
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 24, 1999
Immunotherapy in malignant melanoma
W A Cassel, Z L Olkowski, D R Murray
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
November 11, 1975
The pathogenesis of Vaccinia virus toxicity. II. An electron microscopic study
H M Sottnek, W G Campbell, W A Cassel
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
November 11, 1975
The pathogenesis of Vaccinia virus toxicity. I. The role of virus-platelet interaction
H M Sottnek, W A Cassel, W G Campbell
Page
of 2